4583 On Other Exchanges
Symbol
Exchange
4583 is not on other exchanges.

chiome bioscience inc (4583) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHIOME BIOSCIENCE INC (4583)

Related News

No related news articles were found.

chiome bioscience inc (4583) Related Businessweek News

No Related Businessweek News Found

chiome bioscience inc (4583) Details

Chiome Bioscience Inc. is engaged in the research and development of drug discovery platform technology worldwide. It helps drug discovery companies, such as drug manufacturers and biotech companies to develop antibody drugs through programs based on the autonomously diversifying library system (ADLib system). The ADLib system is a monoclonal antibody generating system that provides various arrays of antibodies in vitro, without using immunization. The company develops the ADLib system to generate therapeutics antibodies; and licenses novel therapeutic antibodies for antigens to pharmaceutical manufactures. Chiome Bioscience Inc. was founded in 2005 and is headquartered in Tokyo, Japan.

Founded in 2005

chiome bioscience inc (4583) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chiome bioscience inc
Chiome Bioscience Inc. Reports Non-Consolidated Earnings Results for the First Quarter Ended March 31, 2017

Chiome Bioscience Inc. reported non-consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported net sales of JPY 55 million, operating loss of JPY 203 million, ordinary loss of JPY 204 million, net loss of JPY 205 million and net loss per share of JPY 7.93 compared to net sales of JPY 51 million, operating loss of JPY 302 million, ordinary loss of JPY 300 million, net loss of JPY 301 million and net loss per share of JPY 13.62 a year ago. Loss before income taxes was JPY 204.564 million against JPY 300.643 million a year ago.

Chiome Bioscience Inc. to Report Q1, 2017 Results on May 15, 2017

Chiome Bioscience Inc. announced that they will report Q1, 2017 results on May 15, 2017

Chiome Bioscience Inc. Reports Non-Consolidated Earnings Results for the Fiscal Year Ended December 31, 2016

Chiome Bioscience Inc. reported non-consolidated earnings results for the fiscal year ended December 31, 2016. For the period, the company reported net sales of JPY 252 million against JPY 280 million a year ago. Operating loss was JPY 1,042 million against JPY 1,269 million a year ago. Ordinary loss was JPY 1,047 million against JPY 1,253 million a year ago. Net loss was JPY 1,491 million against JPY 1,282 million a year ago. Net loss per share was JPY 65.91 against JPY 58.29 a year ago. Negative return on equity was 32.9% compared to 24.8% a year ago. Loss before income taxes was JPY 1,501.280 million against JPY 1,280.695 million a year ago. Net cash used in operating activities was JPY 969.906 million against JPY 1,245.325 million a year ago. Purchase of property and equipment was JPY 10.455 million against JPY 163.789 million a year ago. Purchase of intangible assets was JPY 0.500 million against JPY 4.265 million a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4583 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4583.
View Industry Companies
 

Industry Analysis

4583

Industry Average

Valuation 4583 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 43.7x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHIOME BIOSCIENCE INC, please visit www.chiome.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.